| in CHF m | FY 25/26 | FY 26/27 E | FY 27/28 E | FY 2028 E |
|---|---|---|---|---|
| Sales | 3,605.9 | 3,792.0 | 4,032.3 | 4,288.4 |
| Organic sales growth in local currencies (in %) | 5.4 | 5.5 | 5.3 | 5.3 |
| Total sales growth in local currencies (in %) | 5.9 | 6.8 | 6.4 | 6.4 |
| Total sales Hearing Instruments segment | 3,353.8 | 3,539.5 | 3,762.8 | 4,002.4 |
| Total sales growth Hearing Instruments segment in local currencies (in %) | 7.5 | 7.2 | 6.5 | 6.5 |
| Total sales Cochlear Implants segment | 252.1 | 252.4 | 269.4 | 286.0 |
| Total sales growth Cochlear Implants segment in local currencies (in %) | -11.1 | 2.2 | 6.6 | 6.2 |
| Gross profit (core) | 2,664.7 | 2,775.2 | 2,957.2 | 3,151.2 |
| Gross profit margin (core, in %) | 73.9 | 73.3 | 73.5 | 73.6 |
| Group EBIT (core) | 780.1 | 827.9 | 897.5 | 972.0 |
| Group EBIT margin (core, in %) | 21.6 | 21.8 | 22.2 | 22.6 |
| EBIT growth in local currencies (core, in %) | 13.9 | 8.9 | 8.6 | 8.2 |
This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.